PMID: 11913725Mar 27, 2002Paper

Site-specific molecular design and its relevance to pharmacogenomics and chemical biology

The Pharmacogenomics Journal
D BaileyP Dean

Abstract

The emergence of the new discipline of pharmacogenomics reflects the growing convergence of chemical and genomic space. The massive information-driven growth in both computational chemistry and structural biology is leading to unprecedented opportunities in both chemical and biological design. In this paper we relate current opinion in structural biology to recent developments in computational drug design. Sequence information now permits protein structure prediction and, together with experimental protein structure determination, a complete database of ligand-binding sites and protein-protein interactions can be assembled. When aligned with site exploration and virtual screening, this information provides a foundation for structure-based pharmacogenomics. In association with chemical genomics, structure-based design will allow major new insights into a compound's biological and pharmaceutical properties.

References

Mar 22, 1989·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·D J Danziger, P M Dean
Mar 22, 1989·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·D J Danziger, P M Dean
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·R Sánchez, A Sali
Dec 10, 1998·Nucleic Acids Research·K HofmannA Bairoch
Jan 16, 1999·Current Opinion in Biotechnology·D S BaileyL M Furness
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·M Hendlich
Apr 30, 1999·Science·S A KliewerT M Willson
May 11, 1999·Drug Discovery Today·S Bottomley
Jun 11, 1999·Current Opinion in Structural Biology·M J SternbergR M MacCallum
Aug 24, 1999·Pharmacology & Therapeutics·A Levitzki
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A MatthewsS T Worland
Nov 5, 1999·Journal of Molecular Biology·P E Wright, H J Dyson
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·A PandeyH F Lodish
Feb 19, 2000·Current Opinion in Biotechnology·J F Blake
Feb 26, 2000·Journal of Medicinal Chemistry·T M WillsonB R Henke
Mar 4, 2000·Nature Genetics·U ScherfJ N Weinstein
Mar 17, 2000·Science·J Drews
May 29, 2000·The Journal of Biological Chemistry·M Guerre-MilloB Staels
Jun 24, 2000·Nature·A Pandey, M Mann
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·B A ShoemakerP G Wolynes
Aug 5, 2000·Science·K PalczewskiM Miyano
Aug 10, 2000·Cell·T R HughesS H Friend
Sep 29, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P R GouldsonC A Reynolds
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·M T CancillaJ A Leary
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·J R NewmanP S Kim
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·R A GuptaR N DuBois
Dec 5, 2000·Nature Structural Biology·R SánchezA Sali
Dec 5, 2000·Nature Structural Biology·J M ThorntonC A Orengo
Jan 11, 2000·Nucleic Acids Research·G D BaderC W Hogue
Feb 13, 2001·Drug Discovery Today·D Bailey, D Brown
Feb 22, 2001·Science·J C VenterX Zhu
Feb 24, 2001·Nature·J C RainP Legrain
Feb 24, 2001·Nature·C M SteppanM A Lazar
Feb 24, 2001·Journal of Computer-aided Molecular Design·J E MillsP M Dean
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Mar 20, 2001·Nature Reviews. Genetics·B R Stockwell
Mar 22, 2001·Pharmacogenomics·S R WeinbergerM Pawlak

❮ Previous
Next ❯

Citations

Oct 14, 2005·Bioscience Reports·Ida Chiara Guerrera, Oliver Kleiner
Nov 30, 2005·The Journal of Eukaryotic Microbiology·Huan Zhang, Senjie Lin
Jun 2, 2009·BioTechniques·Sarah Trimpin, Bill Brizzard
Jun 2, 2009·BioTechniques·Sarah Trimpin, Bill Brizzard
Apr 10, 2014·Journal of Bioinformatics and Computational Biology·Anna Zhukova, David J Sherman
Jun 15, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Erinne R DabkowskiJohn M Hollander
Nov 5, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Walter A BaselerJohn M Hollander
Apr 12, 2003·Leukemia & Lymphoma·S ScrivenerA G Prentice

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Structural Biology
A T Brunger, E D Laue
Journal of Biomolecular Structure & Dynamics
Chun-Ting Zhang, Ren Zhang
Proceedings of the National Academy of Sciences of the United States of America
A PertsemlidisT Head-Gordon
© 2022 Meta ULC. All rights reserved